SOAT1 and cancer: The dysregulation of this pathway can occur through mutations in upstream oncogenes, cytokine receptors, JAK, or STAT proteins and are commonly associated with cancer progression: its selective upregulation in response to cytokines drives immune responses, inflammation, and carcinogenesis (5, 6).